Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma

NCT03964753 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Nab-paclitaxel and Cisplatin
PROCEDURE: surgery

Sponsor

Hebei Medical University Fourth Hospital